Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-07-29
2000-04-04
Peselev, Elli
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536124, C07H 100, C07H 300
Patent
active
060463236
ABSTRACT:
The present invention relates to soluble .beta.-glucan compositions. In one embodiment, the invention provides a soluble .beta.-glucan composition which is substantially in a triple helix aggregate conformation under physiological conditions, such as physiological temperature and pH. Such a composition is generally characterized by an aggregate number greater than about 6. The invention further provides methods of preparing .beta.-glucan compositions of this type, as well as methods of characterizing the conformational state of .beta.-glucans.
REFERENCES:
patent: 4138479 (1979-02-01), Truscheit et al.
patent: 4237266 (1980-12-01), Sugiura et al.
patent: 4707471 (1987-11-01), Larm et al.
patent: 4739046 (1988-04-01), Di Luzio
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5328829 (1994-07-01), Stashenko
patent: 5488040 (1996-01-01), Jamas et al.
patent: 5622939 (1997-04-01), Jamas et al.
Manners, D.J., et al., "The Structure of a .beta.-(1.fwdarw.3)-D-Glucan from Yeast Cell Walls," Biochem. J., 135: 19-30 (1973).
Onderdonk, A.B., et al., "Anti-Infective Effect of Poly-.beta.1-6-Glucotriosyl-.beta.1-3-Glucopyranose Glucan In Vivo," Infect. Immun., 60(4): 1642-1647 (1992).
Williams, D.L., et al., "Pre-clinical Safety Evaluation of Soluble Glucan," Int. J. Immunopharmac., 10(4): 405-414 (1988).
Janusz, M.J., et al., "Isolation of Soluble Yeast .beta.-Glucan that Inhibit Human Monocyte Phagocytosis Mediated by .beta.-Glucans Receptors," J. Immunol., 137: 3270-3276 (1986).
Miyazaki, T., et al., "Structural Examination of Antitumour, Water-Soluble Glucans from Grifora umbellata by Use of Four Types of Glucanese," Carbohydrate Research, 65: 235-243 (1978).
Reiskind, J.B. and Mullins, J.T., "Molecular Architecture of the Hyphal Wall of Achlya ambisexualis Raper. II. Ultrastructural Analyses and a Proposed Model," J. Microbiol., 27: 1100-1105 (1981).
Sherwood, E.R., et al., "Soluble Glucan and Lymphokine-activated Killer (LAK) Cells in the Therapy of Experimental Hepatic Metastases," Chemical Abstracts, 108: 179752V (1988).
Williams, D.L. et al., "Pre-clinical Safety Evaluation of Soluble Glucan," Chemical Abstracts, 109: 66566q (1988).
Williams, D.L., et al., "Development of a Water-Soluble, Sulfated (1.fwdarw.3)-.beta.-D-Glucan Biological Response Modifier Derived from Saccharomyces cerevisiae," Carbohydrate Research, 235: 247-257 (1992).
Hara, C., et al., "A Branched (1.fwdarw.3)-.beta.-D-Glucan From a Water Extract of Dictyophora indusiata FISCH," Carb. Res., 145: 237-246 (1986).
Fleet, G.H., et al., "Isolation and Composition of an Alkali-soluble Glucan from the Cell Walls of Saccharomyces cerevisiae," Journal of General Microbiology, 94: 180-192 (1976).
Sherwood, E.R., et al., "Enhancement of Interleukin-1 and Interleukin-2 Production by Soluble Glucan," Int. J. Immunopharmac., 9(3): 261-267 (1987).
Bacon, J., et al., "The Glucan Components of the Cell Wall of Baker's Yeast (Saccharomyces Cerevisiae) Considered in Relation to its Ultrastructure," BioChem. J., 114: 557-567 (1969).
Goldman, R., "Induction of a .beta.-1, 3-D-Glucan Receptor in P388D1 Cells Treated with Retinoic Acid of 1,25-dihydroxyvitamin D.sub.3, " Immunology, 63: 319-324 (1988).
Konopski, Z., et al., "Phagocytosis of .beta.-1,3-D-Glucan-Derivatized Microbeads by Mouse Peritoneal Macrophages Involves Three Different Receptors," Scand. J. Immunol., 33: 297-306 (1991).
Pretus, H.A., et al., "Isolation, Physicochemical Characterization and Preclinical Efficacy Evaluation of Soluble Scleroglucan," The Journal of Pharmacology and Experimental Therapeutics, 500-510 (1991).
Williams, D.L., et al., "Development, Physiocochemical Characterization and Preclinical Efficacy Evaluation of Water Soluble Glucan Sulfate Derived from Saccharomyces cerrevisiae," Immunopharmacology, 22: 139-156 (1991).
Williams, D.L., et al., "A Sequential Multi-Assay Protocol for the Preclinical Assessment of Natural Product Complex Carbohydrate Immunomodulators," Develop. Biol. Standards., 77: 129-136 (1992).
Browder, W., et al., "Beneficial Effect of Enhanced Macrophage Function in the Trauma Patient," Ann. Surg., 211(5): 605-613 (1990).
Chihara, G., et al., "Lentinan as a Host Defense Potentiator (HPD)," Int. J. Immunotherapy, V(4): 145-154 (1989).
Stashenko, P., et al., "Reduction Of Infection-Stimulated Periapical Bone Resorption by a Biological Response Modifier PGG Glucan," J. Dent. Res. 74(1): 323-330 (1995).
Park, Jun T. et al., "Determination of Aggregation Number Distribution (AND) of Biopolymers: A Novel Multi-Detector SEC with Post Column Delivery System," Abstract ACS National Meeting, Las Vegas (Sep. 7-11, 1997).
Guo, Y.A. et al., "Application of Multi-Detector Sec with Post Column Reaction Systems: Conformational Characterization of PGG-Glucan," Abstract ACS Meeting, Las Vegas (Sep. 7-11, 1997).
Yanaki, Toshio, et al., "Triple Helix and Random Coil of Scleroglucan in Dilute Solution," Polymer J., 15(5): 389-396 (1983).
Peselev Elli
The Collaborative Group, Ltd.
LandOfFree
Conformations of PPG-glucan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conformations of PPG-glucan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformations of PPG-glucan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-366505